Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-03 4:26 pm Purchase | 2025-09-26 | 13D | SAB BIOTHERAPEUTICS INC NE SABS | RA Capital Management, L.P. | 4,401,500 9.900% | 4,401,500 (New Position) | Filing History |
| 2025-10-01 9:19 pm Purchase | 2025-09-29 | 13D | ARS PHARMACEUTICALS, INC SPRY | RA Capital Management, L.P. | 10,940,977 11.100% | 80,000 (+0.74%) | Filing History |
| 2025-09-30 4:36 pm Purchase | 2025-09-26 | 13D | PEPGEN INC PEPG | RA Capital Management, L.P. | 20,099,753 29.200% | 9,404,618 (+87.93%) | Filing History |
| 2025-09-19 4:53 pm Purchase | 2025-09-17 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 1,988,657 29.000% | 1,664 (+0.08%) | Filing History |
| 2025-09-19 4:47 pm Purchase | 2025-09-12 | 13G | LB PHARMACEUTICALS INC LBRX | RA Capital Management, L.P. | 1,675,000 7.500% | 1,675,000 (New Position) | Filing History |
| 2025-09-08 6:00 pm Purchase | 2025-09-04 | 13D | MINERALYS THERAPEUTICS INC MLYS | RA Capital Management, L.P. | 7,796,433 9.900% | 1,508,836 (+24.00%) | Filing History |
| 2025-08-29 4:32 pm Purchase | 2025-08-22 | 13G | INVIVYD, INC. IVVD | RA Capital Management, L.P. | 21,338,288 9.900% | 21,338,288 (New Position) | Filing History |
| 2025-08-26 4:59 pm Purchase | 2025-06-30 | 13G | ADAGIO MED INC ADGM | RA Capital Management, L.P. | 1,200,000 7.200% | 1,200,000 (New Position) | Filing History |
| 2025-08-20 4:41 pm Purchase | 2025-06-30 | 13G | CERVOMED INC CRVO | RA Capital Management, L.P. | 1,026,937 9.900% | 1,026,937 (New Position) | Filing History |
| 2025-08-18 5:52 pm Purchase | 2025-08-11 | 13G | ASSEMBLY BIOSCIENCES INC N ASMB | RA Capital Management, L.P. | 1,530,615 9.500% | 902,523 (+143.69%) | Filing History |
| 2025-08-14 6:14 pm Sale | 2025-06-30 | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | RA Capital Management, L.P. | 593,670 0.700% | -5,417,442 (-90.12%) | Filing History |
| 2025-08-14 6:13 pm Sale | 2025-06-30 | 13G | UROGEN PHARMA LTD URGN | RA Capital Management, L.P. | 0 0.000% | -3,206,271 (Position Closed) | Filing History |
| 2025-08-14 6:11 pm Purchase | 2025-06-30 | 13G | TAYSHA GENE THERAPIES INC TSHA | RA Capital Management, L.P. | 25,345,988 9.900% | 3,806,523 (+17.67%) | Filing History |
| 2025-08-14 6:10 pm Sale | 2025-06-30 | 13G | SUTRO BIOPHARMA INC STRO | RA Capital Management, L.P. | 0 0.000% | -443,464 (Position Closed) | Filing History |
| 2025-08-14 6:08 pm Sale | 2025-06-30 | 13G | SERA PROGNOSTICS INC SERA | RA Capital Management, L.P. | 0 0.000% | -3,032,808 (Position Closed) | Filing History |
| 2025-08-14 6:06 pm Purchase | 2025-08-12 | 13D | SOLID BIOSCIENCES INC SLDB | RA Capital Management, L.P. | 7,997,510 9.900% | 7,690 (+0.10%) | Filing History |
| 2025-08-14 6:04 pm Sale | 2025-06-30 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | RA Capital Management, L.P. | 5,561,359 8.700% | -523,053 (-8.60%) | Filing History |
| 2025-08-14 6:03 pm Sale | 2025-06-30 | 13G | PROTARA THERAPEUTICS INC TARA | RA Capital Management, L.P. | 1,971,765 4.900% | -1,459,948 (-42.54%) | Filing History |
| 2025-08-14 6:01 pm Purchase | 2025-06-30 | 13G | GH RESH PLC SHS GHRS | RA Capital Management, L.P. | 7,676,697 12.400% | 732,049 (+10.54%) | Filing History |
| 2025-08-14 6:00 pm Sale | 2025-06-30 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | RA Capital Management, L.P. | 0 0.000% | -5,755,577 (Position Closed) | Filing History |